r INVA Stock Quote - Innoviva, Inc. Stock Price Today
TONIGHT! Join in as Kyle Dennis, 27 year-old,
self-made millionaire, reveals his newest trading strategy.
Days
Hours
Minutes
Seconds

Innoviva, Inc.
(NASDAQ : INVA)

( )
INVA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.61%165.500.4%$265.48m
VRXValeant Pharmaceuticals International, Inc.
0.00%22.2214.1%$212.77m
PRGOPerrigo Co. Plc
0.00%75.126.7%$104.81m
JAZZJazz Pharmaceuticals Plc
0.00%163.582.2%$90.19m
PTLAPortola Pharmaceuticals, Inc.
0.00%40.017.7%$76.83m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.00%159.967.6%$65.24m
SAGESAGE Therapeutics, Inc.
0.00%158.179.6%$60.16m
MNKMallinckrodt Plc
0.00%16.4421.1%$56.93m
SUPNSupernus Pharmaceuticals, Inc.
0.00%55.656.3%$48.08m
UTHRUnited Therapeutics Corporation
0.00%104.7314.4%$37.24m
CTLTCatalent Inc
0.00%38.812.6%$31.45m
ICPTIntercept Pharmaceuticals, Inc.
0.00%69.7621.8%$30.80m
ENDPEndo International Plc
0.00%6.268.9%$29.69m
IRWDIronwood Pharmaceuticals, Inc. Class A
0.00%17.5710.2%$25.85m
ICLRICON Plc
0.00%124.314.2%$25.10m

Company Profile

Innoviva, Inc. engages in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Brisbane, CA.